17th Discovery on Target 2019
-第17届标靶发现年度会议-
日期:2019年9月16-19日
地点:美国马萨诸塞州波士顿,Westin Copley Place




主题演讲

David LiuBase Editing: Chemistry on a Target Nucleotide in the Genome of Living Cells
David R. Liu, PhD, Howard Hughes Medical Institute Investigator, Professor of Chemistry & Chemical Biology, Harvard University

Crews_CraigPROTACs: Past, Present, and Future
Craig M. Crews, PhD, Professor, Chemistry; Pharmacology; Molecular, Cellular & Developmental Biology; Yale University

Additional Keynote Speakers to be Announced

> View Details

矚目演讲者

John Doench, PhD
Broad Institute of Harvard and MIT

Bryan Fuchs, PhD
Ferring Research Institute

Nathanael S. Gray, PhD
Dana-Farber Cancer Institute

Stephen J. Haggarty, PhD
Harvard Medical School & Massachusetts General Hospital

Cory M. Hogaboam, PhD
Cedars-Sinai Medical Center

Dean Hum, PhD
Genfit

Paul A. Insel, MD
University of California, San Diego

Ian James, PhD
Trevena, Inc.

Christine Lavoie, PhD
University of Sherbrooke

Elliott Nickbarg, PhD
Merck & Co, Inc.

Andrew Nixon, PhD
Boehringer Ingelheim

J. Brad Shotwell, PhD
AbbVie

Rebecca Taub, MD
Madrigal Pharmaceuticals

Peter M. Tessier, PhD
University of Michigan

Shaomeng Wang, PhD
University of Michigan

Kevin Weeks, PhD
University of North Carolina



关于本会议

2019年9月16日至19日在美国麻州波士顿举行的第17届Discovery on Target (DOT),是发现新药物标的与技术为主题的制药业界重要活动,超过1300位药物发现领域的专职人员将在此聚集。会议将聚焦于备受注目的药物发现标的及技术领域的研究成果、包含生物制剂及小分子药物在内,对应新疗法发现与开发的标的验证策略,与会者可从14项主题单元中选取有兴趣者参与。此外,深入探讨特定主题的研讨会、网罗广泛主题的短期课程、由各领域专家主持的小组讨论、交流活动等也在预定之中,连同所属组织在内的研究面需求也都将获得满足。

2019年的活动除了扩充了蛋白质工程与新生物制剂相关主题单元之外,也加入了蛋白质分解诱导药物(PROTAC)及其应用领域、纤维症领域的药物与标的、癌症免疫疗法新标的、作为小分子药物新标的RNA等议程。


赞助商

Choose your language
Chinese
Japanese
Korean
English





Premier Sponsors

AbCellera

Ablexis Alivamab_stacked

Charles-River

Eurofins

Integral

OmniAb Ligand_Pharmaceuticals

Synthego



免费电子邮件通知服务